• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. PULSE GEN MODEL 103; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. PULSE GEN MODEL 103; GENERATOR Back to Search Results
Model Number 103
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Seizures (2063)
Event Date 06/06/2019
Event Type  Injury  
Event Description
The patient reported that they experienced stronger seizures than normal.The patient also believed that their seizure frequency had increased; and a representative reported that the patient had three seizures while in the patient room.Multiple attempts for additional information were made to the patient's following neurologist; however, no further relevant information has been received to date.No known relevant surgical intervention has occurred to date.
 
Event Description
Product analysis was completed on the returned generator.The reported increase in seizures could not be evaluated in product analysis; however, proper functionality of the pulse generator and its ability to provide appropriate programmed output currents was verified in product analysis.The device output signal was monitored for more than 24-hours while the pulse generator was placed in a simulated body temperature environment.Results showed no signs of variation in the output signal and demonstrated the device provided expected level of output current for the entire monitoring period.Magnet activations performed one inch using spacer block demonstrated the appropriate magnet output for the programmed settings.Diagnostics were as expected for the programmed parameters.A comprehensive automated electrical evaluation showed that the generator performed according to functional specifications.There were no performance or any other type of adverse conditions found with the pulse generator.No further relevant information has been received to date.
 
Event Description
It was reported that the patient's generator was explanted due to reported battery depletion.The generator was received by the manufacturer for product analysis; however, product analysis has not been completed to date.No further relevant information has been received to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 103
Type of Device
GENERATOR
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
rachel kohn
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key8751322
MDR Text Key149758198
Report Number1644487-2019-01253
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/01/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/10/2012
Device Model Number103
Device Lot Number201513
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/18/2019
Is the Reporter a Health Professional? Yes
Event Location Other
Date Manufacturer Received01/14/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/09/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age47 YR
-
-